ENDRA Life Sciences Inc. (NDRA) Stock Overview
Explore ENDRA Life Sciences Inc.’s financial performance, market position, analyst ratings, and future outlook.
ENDRA Life Sciences Inc. (NDRA)
Key Financials
Key Financials
Market Cap
6M
P/E Ratio
-0.78
EPS (TTM)
$-7.81
ROE
-2.25%
NDRA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of ENDRA Life Sciences Inc. (NASDAQ: NDRA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, ENDRA Life Sciences Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NDRA on the NASDAQ shows an RSI of 53.99, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $276.44 for the NASDAQ listing.
Key metrics behind ENDRA Life Sciences Inc.'s NASDAQ-traded stock include a P/E ratio of -0.78 and a market capitalization of 6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NDRA on the NASDAQ.